| Identification | Back Directory | [Name]
ZLD-1039 | [CAS]
1826865-46-6 | [Synonyms]
ZLD-1039
3-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-N-[(2
8-hexahydro-1-methyl-3-oxo-4-isoquinolinyl)methyl]-2-methyl-5-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]-benzamide
3-[ETHYL(TETRAHYDRO-2H-PYRAN-4-YL)AMINO]-N-[(2;3;5;6;7;8-HEXAHYDRO-1-METHYL-3-OXO-4-ISOQUINOLINYL)METHYL]-2-METHYL-5-[6-(4-METHYL-1-PIPERAZINYL)-3-PYRIDINYL]-BENZAMIDE
Benzamide, 3-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-N-[(2,3,5,6,7,8-hexahydro-1-methyl-3-oxo-4-isoquinolinyl)methyl]-2-methyl-5-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]- | [Molecular Formula]
C36H48N6O3 | [MDL Number]
MFCD32710289 | [MOL File]
1826865-46-6.mol | [Molecular Weight]
612.8 |
| Chemical Properties | Back Directory | [Boiling point ]
826.8±65.0 °C(Predicted) | [density ]
1.24±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO: soluble | [form ]
A crystalline solid | [pka]
12.15±0.60(Predicted) | [color ]
Off-white to gray | [InChIKey]
SZAYCVHJDOWSNY-UHFFFAOYSA-N | [SMILES]
C(NCC1=C2C(=C(C)NC1=O)CCCC2)(=O)C1=CC(C2=CC=C(N3CCN(C)CC3)N=C2)=CC(N(CC)C2CCOCC2)=C1C |
| Hazard Information | Back Directory | [Uses]
ZLD1039 is a potent, highly selective, and orally bioavailable EZH2 inhibitor. ZLD1039 shows potent and concentration-dependent inhibition of PRC2 enzymatic activity against EZH2 wild-type as well as Y641F, and A677G mutant enzymes with IC50 values of 5.6, 15, and 4.0?nM, respectively. ZLD1039 inhibits breast tumor growth and metastasis[1]. | [storage]
Store at -20°C | [References]
[1] Xuejiao Song, et al. Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer. Sci Rep. 2016; 6: 20864. |
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 |
| Website: |
https://www.weikeqi-biotech.com/ |
|